- Home
- RSKD vs QURE Comparison
RSKD vs QURE Comparison
Compare RSKD & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSKD
- QURE
- Stock Information
- Founded
- RSKD 2012
- QURE 1998
- Country
- RSKD United States
- QURE Netherlands
- Employees
- RSKD N/A
- QURE N/A
- Industry
- RSKD EDP Services
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- RSKD Technology
- QURE Health Care
- Exchange
- RSKD Nasdaq
- QURE Nasdaq
- Market Cap
- RSKD 796.4M
- QURE 725.4M
- IPO Year
- RSKD 2021
- QURE 2007
- Fundamental
- Price
- RSKD $4.95
- QURE $14.21
- Analyst Decision
- RSKD Hold
- QURE Strong Buy
- Analyst Count
- RSKD 8
- QURE 10
- Target Price
- RSKD $6.03
- QURE $37.20
- AVG Volume (30 Days)
- RSKD 543.4K
- QURE 1.2M
- Earning Date
- RSKD 08-13-2025
- QURE 07-31-2025
- Dividend Yield
- RSKD N/A
- QURE N/A
- EPS Growth
- RSKD N/A
- QURE N/A
- EPS
- RSKD N/A
- QURE N/A
- Revenue
- RSKD $333,495,000.00
- QURE $20,201,000.00
- Revenue This Year
- RSKD $5.92
- QURE $27.16
- Revenue Next Year
- RSKD $9.38
- QURE $248.21
- P/E Ratio
- RSKD N/A
- QURE N/A
- Revenue Growth
- RSKD 9.30
- QURE 6.30
- 52 Week Low
- RSKD $3.94
- QURE $3.73
- 52 Week High
- RSKD $6.65
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- RSKD 50.81
- QURE 44.61
- Support Level
- RSKD $4.82
- QURE $14.75
- Resistance Level
- RSKD $5.29
- QURE $15.35
- Average True Range (ATR)
- RSKD 0.15
- QURE 1.05
- MACD
- RSKD -0.03
- QURE -0.27
- Stochastic Oscillator
- RSKD 43.22
- QURE 10.79
About RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.